08/07/2022at 15:17

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix

Another hurdle overcome in delaying MDR deadline

EU member countries have voted unanimously to adopt an EU Commission proposal to stagger the implementation of the new Medical Device Regulation. Now, only the EU Parliament’s vote remains.

For subscribers

Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Other

Top news from MedWatch this week

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology

Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Novo Nordisk declared world's best place to work in 2022

The Best Places to Work organization has released its 2022 list of the best workplaces across the world, and Danish Novo Nordisk shines at the top.

For subscribers

Pharma & biotech

Novo Nordisk CEO rakes in cash in record year

Being at the top of Denmark’s most valuable company is lucrative, Novo Nordisk reveals in its annual report – and Chief Executive Lars Fruergaard Jørgensen is making a killing there.

For subscribers

Lars Fruergaard Jørgensen, CEO at Novo Nordisk | Foto: Stine Bidstrup

Pharma & biotech

Potential blockbuster submitted by Novo Nordisk for European approval

The EMA can begin reviewing hemophilia treatment concizumab, which used to carry the orphan drug badge until recently, when the company decided not to take advantage of the status.

For subscribers

Latest news

See all

Jobs

See all jobs

Jobs

See all jobs

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Top news from MedWatch this week

Monday

Tuesday

Wednesday

Thursday

Friday

Sign up for our newsletter

Front page now

Another hurdle overcome in delaying MDR deadline

Novo Nordisk hopes to retain employees with share gift

Top news from MedWatch this week

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

Coloplast launches male catheter featuring new technology

Coloplast's bottom line disappoints in otherwise strong report

Further reading

Novo Nordisk declared world's best place to work in 2022

Novo Nordisk CEO rakes in cash in record year

Potential blockbuster submitted by Novo Nordisk for European approval

Latest news

Jobs

Jobs